Navamedic ASA will present its fourth quarter 2016 report in an extended event on Wednesday, February 15 2017 at Hotel Continental in Oslo, Norway. Navamedic is proud to announce Prof. Jan Van Der Linden from Karolinska Institutet as keynote speaker for the session focusing on the Sippi® technology platform and market opportunities.
Agenda (times in CET):
08:00-08:20 : Q4 2016 presentation by Tom Rönnlund, CEO of Navamedic AB
08:25-08:30 : Break
08:30-08:55 : Current research Sippi-Jan Van Der Linden, Professor and Senior Physician at Karolinska Institutet, Department of Molecular Medicine and Surgery and Research group leader of the group Cardiothoracic Anesthesiology and Intensive Care.
08:55-09:15 : Magnus Emmoth, CEO of Navamedic Medtech AB
A light breakfast will be served from 07:30.
The presentation will be live streamed at www.navamedic.com . Streaming details to follow at a later date.
For further information, please contact:
Toril Ås, CFO of Navamedic
Phone: +47 671 12 540
Navamedic ASA is a Norwegian medtech and pharmaceutical products company, delivering products to patients, hospitals and pharmacies in the Nordic and Benelux markets. The Group's Medtech business has developed and is currently introducing the next generation of digital urine meter Sippi®. Navamedic's Pharma and Healthcare business is a distributor of products supplied by a number of pharmaceutical manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA).